A Clinical Trial to Evaluate the Effects of a Supplement on Symptoms Associated With Liver and Digestive Health | NCT07738744

NCT07738744

Overview

NCT ID: NCT07738744
Lead Sponsor: EdenboostINDUSTRY
Official Title: A Clinical Trial to Evaluate the Effects of a Supplement on Symptoms Associated With Liver and Digestive Health
Brief Summary: This study will evaluate the effects of Edenboost Alpha Cleanse, a dietary supplement, on symptoms associated with liver and digestive health. The study is a single-arm, open-label trial in which all 40 enrolled participants will use the test product daily for 12 weeks.

Participants will complete questionnaires at Baseline, Week 4, Week 8, and Week 12, and will undergo blood testing (hepatic function panel) at Baseline and Week 12. Primary outcomes focus on changes in liver function biomarkers, while secondary outcomes capture participants' self-reported experiences of energy levels, abdominal bloating, abdominal pain, fatigue, and nausea.
Conditions: Liver Health
Digestive Health
Fatigue

Status and Timeline

Status: Completed
Last Update Posted: Jul 31, 2026Actual
Start Date: Nov 17, 2025Actual
Primary Completion Date: Jan 15, 2026Actual
Completion Date

Participation Criteria

Ages Eligible for Study: Adult (18-64)Older Adult (65+)
Sexes Eligible for Study: All
Accepts Healthy Volunteers?: No
Eligibility Criteria: Inclusion Criteria:

Be male or female.

Be aged 40-65.

Anyone who has struggled with low energy levels and fatigue over the past four weeks.

Anyone who has struggled with at least two of the following symptoms over the past four weeks: abdominal bloating, abdominal discomfort, constipation, diarrhea, digestive discomfort.

Willing to maintain the same diet, sleep pattern, and exercise regimen consistently throughout the study duration.

If taking any other supplements, medications, or herbal remedies, has been doing so consistently for at least three months and is willing to maintain this routine for the duration of the trial.

Willing to avoid introducing any other supplements, medications, or herbal remedies for the duration of the trial.

Resides in the United States.

Exclusion Criteria:

Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including mental health disorders, a history of serious illness in the last three months, a history of substance abuse, or planned surgery during the study period.

Anyone with a known history of severe digestive disorders like acid reflux, peptic ulcers, Irritable Bowel Syndrome (IBS), Irritable Bowel Disease (IBD), GI bleeding, Crohn's disease, Ulcerative Colitis (UC), or gastrointestinal tract surgeries.

Anyone with a history of kidney stones.

Anyone with any allergies or sensitivities to any of the study product ingredients.

Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).

Anyone on Coumadin (warfarin) or antiplatelet therapy (e.g., Plavix (clopidogrel), aspirin).

Anyone with uncontrolled chronic disease, including but not limited to diabetes, hypertension (high blood pressure), and thyroid-related conditions.

Anyone unwilling to follow the study protocol.

Anyone who is currently a smoker or has been a smoker in the past 3 months.

Currently partaking in another research study or will be partaking in any other research study at any point during this study's duration.

Study Plan

Study Type: Interventional
Phase: Not Applicable
Enrollment: 40Actual
Primary Purpose: Treatment
Allocation: N/A
Interventional Model: Single Group Assignment
Masking: None (Open Label)

Contacts and Locations

Central Contacts: No data available
Locations: Citruslabs

Overview

Status and Timeline

Participation Criteria

Study Plan

Contacts and Locations

Similar Studies